Saturday 12 July 2025

The Pharma Letter Podcast — Episode 34 — Is this a revolution in Alzheimer's?

Pharmaceutical
Simon Wentworth
12 June 2025

More on this story...

Biotechnology
Positive top-line Alzheimer’s disease data from NewAmsterdam
10 June 2025
Pharmaceutical
Dementia Discovery Fund takes total fundraising beyond $550 million
21 May 2025
Biotechnology
AriBio and Arcera sign $600 million licensing and supply agreements
11 June 2025


Company News Directory



Companies featured in this story

More ones to watch >


Today's issue

CSL Seqirus ships first flu jabs for the US 2025/26 season
Pharmaceutical
CSL Seqirus ships first flu jabs for the US 2025/26 season
11 July 2025
Biotechnology
FDA slaps CRL on Capricor’s deramiocel BLA
11 July 2025
Pharmaceutical
EMA’s PRAC completes reviews of Ixchiq and varicella vaccines
11 July 2025
Biotechnology
NICE recommends Omvoh for previously-treated Crohn’s disease
11 July 2025
Biotechnology
Renasant Bio launches with eyes on polycystic kidney disease
11 July 2025
Pharmaceutical
Hefty Nuclidium fundraiser latest evidence of radiopharma boom
11 July 2025
Biotechnology
BrainXell names Katherine Vega Stultz as CEO
11 July 2025

Company Spotlight

A global biotech developing of novel antibody-based drugs with innovative technologies.




More Features in Pharmaceutical

CSL Seqirus ships first flu jabs for the US 2025/26 season
11 July 2025
EMA’s PRAC completes reviews of Ixchiq and varicella vaccines
11 July 2025
Hefty Nuclidium fundraiser latest evidence of radiopharma boom
11 July 2025
TandemAI and Perpetual Medicines merge
11 July 2025


Copyright © The Pharma Letter 2025   |   Headless Content Management with Blaze